A human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

Details for Australian Patent Application No. 2004299457 (hide)

Owner Government of the United States of America, as represented by the Secretary Department of Health and Human Services

Inventors Schlom, Jeffrey; Tsang, Kwong-Yok

Agent Pizzeys

Pub. Number AU-B-2004299457

PCT Pub. Number WO2005/058937

Priority 60/529,329 12.12.03 US

Filing date 10 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 24 March 2011

International Classifications

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058937 Priority application(s): WO2005/058937

24 March 2011 Application Accepted

  Published as AU-B-2004299457

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004299459-Doxepin analogs and methods of use thereof

2004299456-(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists